Twist Bioscience's Series B Round

Twist Bioscience raised a round of funding on May 27, 2014.

Twist Bioscience is a biotechnology company offering synthetic DNA production for specialty chemical compounds and drug development. By synthesizing DNA on silicon instead of on traditional 96-well pl…

Articles about Twist Bioscience's Series B Round: